Please assess the completion status of the following clinical trial:

Trial Title: A Randomized, Double-Blinded Study of Simvastatin 20 mg/Day Versus Vytorin 10/20 in Subjects With Lipid Profiles Not Meeting Current NCEP Guidelines, Following a Low-Carbohydrate Diet

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Moderately obese with hyperlipidemia~Exclusion Criteria:~* Recent unstable heart or lung condition~* Current use of other lipid modifying drugs~* Hepatic disease~* Pregnancy or lactation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- 2 (Type: EXPERIMENTAL): Low carb diet plus simvastatin 20 mg/ezetimibe 10 mg

Based on this trial design, predict the completion outcome and termination type (if applicable).